Morphological changes in the placenta as an indicator of the effectiveness of preventive measures in pregnant women with a high risk of fetal growth restriction
- Authors: Kuneshko N.F.1, Ershov A.V.2, Dobrokhotova Y.E.3, Lazarchuk A.V.2
-
Affiliations:
- Odintsovo Regional Hospital
- Sechenov First Moscow State Medical University (Sechenov University)
- Pirogov Russian National Research Medical University (Pirogov University)
- Issue: Vol 27, No 7 (2025): Women’s and men’s health
- Pages: 409-414
- Section: Articles
- URL: https://ogarev-online.ru/2075-1753/article/view/309802
- DOI: https://doi.org/10.26442/20751753.2025.7.203355
- ID: 309802
Cite item
Full Text
Abstract
Background. Many of the factors that influence placental formation are modifiable and can be corrected by pre-conception care, which plays an important role in the prevention of placental insufficiency.
Aim. To assess the effectiveness of pre-conception care and treatment and preventive measures in women at high risk of placental insufficiency and fetal growth restriction based on a pathomorphological study of the placenta.
Materials and methods. An analysis of 733 pregnancy and birth histories was performed, including ultrasound protocols and conclusion of the results of pathological and histological examination of the placentas. Five groups were identified: A (n=87) pre-conception care was carried out, B (n=195) were admitted for observation for a period of 8–16 weeks, C (n=191) – for a period of 16–24 weeks, D (n=148) – after 25 weeks in the absence of therapeutic and preventive measures earlier. Control group included 112 healthy pregnant women.
Results. The most pronounced pathological changes were in the placenta of women of group G. In women of group A, changes in the placenta were comparable to those in the control group, which indicates the success of the measures taken in the prevention of placental insufficiency. In women of subgroup B timely correction of abnormalities and risk factors also contributed to the favorable pathomorphological and functional state of the placenta and the favorable course and outcome of pregnancy.
Conclusion. The study demonstrated that pre-conception care and early preventive measures in women at high risk of fetal growth restriction significantly reduce the frequency and severity of pathological placental changes, promoting favorable pregnancy outcomes. The most pronounced abnormalities were observed in women who started prenatal care in the later stages, highlighting the importance of early diagnosis and individualized pregnancy management.
Full Text
##article.viewOnOriginalSite##About the authors
Nart F. Kuneshko
Odintsovo Regional Hospital
Email: arina.lazarchuk@mail.ru
ORCID iD: 0000-0002-2754-5129
Cand. Sci. (Med.)
Russian Federation, OdintsovoAnton V. Ershov
Sechenov First Moscow State Medical University (Sechenov University)
Email: arina.lazarchuk@mail.ru
ORCID iD: 0000-0001-5758-8552
D. Sci. (Med.)
Russian Federation, MoscowYuliya E. Dobrokhotova
Pirogov Russian National Research Medical University (Pirogov University)
Email: arina.lazarchuk@mail.ru
ORCID iD: 0000-0003-2786-6181
D. Sci. (Med.), Prof.
Russian Federation, MoscowArina V. Lazarchuk
Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: arina.lazarchuk@mail.ru
ORCID iD: 0000-0003-2136-1641
Clinical Resident
Russian Federation, MoscowReferences
- Amelio GS, Provitera L, Raffaeli G, et al. Endothelial dysfunction in preterm infants: The hidden legacy of uteroplacental pathologies. Front Pediatr. 2022;10:1041919. doi: 10.3389/fped.2022.1041919
- King VJ, Bennet L, Stone PR, et al. Fetal growth restriction and stillbirth: Biomarkers for identifying at risk fetuses. Front Physiol. 2022;13:959750. doi: 10.3389/fphys.2022.959750
- Рinheiro B, Sarmento-Gonçalves I, Ramalho C. Association Between Placental Pathology and Early-Onset Fetal Growth Restriction: A Systematic Review. Fetal Pediatr Pathol. 2025;44(1):40-52. doi: 10.1080/15513815.2024.2437642
- Sun C, Groom KM, Oyston C, et al. The placenta in fetal growth restriction: What is going wrong? Placenta. 2020;96:10-8. doi: 10.1016/j.placenta.2020.05.003
- Сидоркина А.Г., Мудров В.А. Современные представления о патогенезе развития хронической плацентарной недостаточности. Российский вестник акушера-гинеколога. 2024;24(1):12-8 [Sidorkina AG, Mudrov VA. Modern ideas about the pathogenesis of chronic placental insufficiency. Russian Bulletin of Obstetrician-Gynecologist. 2024;24(1):12-8 (in Russian)]. doi: 10.17116/rosakush20242401112
- McIntyre KR, Hayward CE, Sibley CP, et al. Evidence of adaptation of maternofetal transport of glutamine relative to placental size in normal mice, and in those with fetal growth restriction. J Physiol. 2019;597(19):4975-90. doi: 10.1113/JP278226
- Simcox LE, Myers JE, Cole TJ, Johnstone ED. Fractional fetal thigh volume in the prediction of normal and abnormal fetal growth during the third trimester of pregnancy. Am J Obstet Gynecol. 2017;217(4):453.e1-453.e12. doi: 10.1016/j.ajog.2017.06.018
- Zur RL, Kingdom JC, Parks WT, Hobson SR. The Placental Basis of Fetal Growth Restriction. Obstet Gynecol Clin North Am. 2020;47(1):81-98. doi: 10.1016/j.ogc.2019.10.008
- Низяева Н.В., Волкова Ю.С., Муллабаева С.М., Щеголев А.И. Методические основы изучения ткани плаценты и оптимизация режимов предподготовки материала. Акушерство и гинекология. 2014;8 [Nizyaeva NV, Volkova YuS, Mullabaeva SM, Shchegolev A.I. The methodical bases for placental tissue examination and the optimization of material pre-preparation regimens. Obstetrics and Gynecology. 2014;8 (in Russian)].
- Динер Н.М., Узлова Т.В., Кирсанов М.С. Хроническая плацентарная недостаточность: вопросы диагностики и акушерской тактики. Вестник Уральской медицинской академической науки. 2016;3:5-13 [Diner NM, Uzlova TV, Kirsanov MS. Chronical placental insufficiency: questions of diagnostics and obstetric management. Bulletin of Ural Medical Academic Science. 2016;3:5-13 (in Russian)]. doi: 10.22138/2500-0918-2016-15-3-5-13
- Стрижаков А.Н., Мирющенко М.М., Игнатко И.В., и др. Прогнозирование синдрома задержки роста плода у беременных высокого риска. Акушерство и гинекология. 2017;7:34-44 [Strizhakov AN, Miryushchenko MM, Ignatko IV, et al. Prediction of fetal growth restriction in high-risk pregnant women. Obstetrics and Gynecology. 2017;7:34-44 (in Russian)]. doi: 10.18565/aig.2017.7.34-44
- Dumolt JH, Powell TL, Jansson T. Placental Function and the Development of Fetal Overgrowth and Fetal Growth Restriction. Obstet Gynecol Clin North Am. 2021;48(2):247-66. doi: 10.1016/j.ogc.2021.02.001
- Daggett EE, Ananth CV. Ischemic Placental Disease: Epidemiology and Impact on Maternal and Offspring Health Along the Life Course. Clin Obstet Gynecol. 2025;68(1):105-10. doi: 10.1097/GRF.0000000000000914
- Burton GJ, Jauniaux E. Pathophysiology of placental-derived fetal growth restriction. Am J Obstet Gynecol. 2018;218(2S):S745-61. doi: 10.1016/j.ajog.2017.11.577
- ACOG Practice Bulletin No. 204. Fetal growth restriction. Obstet Gynecol. 2019;133(2):e97-109. doi: 10.1097/AOG.0000000000003070
- Baschat AA. Planning management and delivery of the growth-restricted fetus. Best Pract Res Clin Obstet Gynaecol. 2018;49:53-65. doi: 10.1016/j.bpobgyn.2018.02.009
- Covarrubias A, Aguilera-Olguín M, Carrasco-Wong I, et al. Feto-placental Unit: From Development to Function. Adv Exp Med Biol. 2023;1428:1-29. doi: 10.1007/978-3-031-32554-0_1
- Lee AC, Kozuki N, Cousens S, et al. CHERG Small-for-Gestational-Age-Preterm Birth Working Group. Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets. BMJ. 2017;358:j3677. doi: 10.1136/bmj.j3677
- Kingdom JC, Audette MC, Hobson SR, et al. A placenta clinic approach to the diagnosis and management of fetal growth restriction. Am J Obstet Gynecol. 2018;218(2S):S803-17. doi: 10.1016/j.ajog.2017.11.575
- Нong J, Crawford K, Daly M, et al. Utility of placental biomarkers and fetoplacental Dopplers in predicting likely placental pathology in early and late fetal growth restriction – A prospective study. Placenta. 2024;156:20-9. doi: 10.1016/j.placenta.2024.08.016
- Баринова И.В., Котов Ю.Б., Скляренко Г.А., и др. Диагностическая ценность массы плаценты как критерия функционального состояния фетоплацентарного комплекса. Российский вестник акушера-гинеколога. 2010;10(5):3-6 [Barinova IV, Kotov IuB, Skliarenko GA, et al. Diagnostic value of placental mass as a criterion for the functional state of the fetoplacental complex. Russian Bulletin of Obstetrician-Gynecologist. 2010;10(5):3-6 (in Russian)].
- Степанян Л.В., Петраева И.Д., Волобаева С.Н. Патолого-гистологическая картина плаценты при фето-плацентарной недостаточности. Евразийский Союз Ученых. 2018;9(54):42-4 [Stepanian LV, Petraeva ID, Volobaeva SN. Patologo-gistologicheskaia kartina placenty pri feto-placentarnoi nedostatochnosti. Evraziiskii Soiuz Uchenyh. 2018;9(54):42-4 (in Russian)].
- Brouwers L, de Gier S, Vogelvang TE, Veerbeek JHW, et al. Prevalence of placental bed spiral artery pathology in preeclampsia and fetal growth restriction: A prospective cohort study. Placenta. 2024;156:1-9. doi: 10.1016/j.placenta.2024.08.010
- de Barros Mucci D, Kusinski LC, Wilsmore P, et al. Impact of maternal obesity on placental transcriptome and morphology associated with fetal growth restriction in mice. Int J Obes (Lond). 2020;44(5):1087-96. doi: 10.1038/s41366-020-0561-3
- Tanner LD, Brock And C, Chauhan SP. Severity of fetal growth restriction stratified according to maternal obesity. J Matern Fetal Neonatal Med. 2022;35(10):1886-90. doi: 10.1080/14767058.2020.1773427
- Brink LT, Springer PE, Nel DG, et al. The tragedy of smoking, alcohol, and multiple substance use during pregnancy. S Afr Med J. 2022;112(8):526-38. doi: 10.7196/SAMJ.2022.v112i8.16480
- Stepan H, Hund M, Andraczek T. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome. Hypertension. 2020;75(4):918-26. doi: 10.1161/HYPERTENSIONAHA.119.13763
Supplementary files
